Authors:
WOLMARK N
PIEDBOIS P
ROUGIER P
BUYSE M
PIGNON JP
RYAN L
HANSEN R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
BRUFMAN G
ISACSON R
LAPLANCHE A
LEVY E
HARRINGTON D
MCFADDEN E
RIBBLE A
JACOBSON R
LUBOINSKI M
VAITKEVICIUS V
LEBOURGEOIS JP
PIEDBOIS Y
GAUTHIER E
DURANDZALESKI I
CARLSON R
RUSTUM Y
ERLICHMAN C
Citation: N. Wolmark et al., EFFICACY OF INTRAVENOUS CONTINUOUS-INFUSION OF FLUOROURACIL COMPARED WITH BOLUS ADMINISTRATION IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 301-308
Authors:
DURANDZALESKI I
EARLAM S
FORDY C
DAVIES M
ALLENMERSH TG
Citation: I. Durandzaleski et al., COST-EFFECTIVENESS OF SYSTEMIC AND REGIONAL CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE COLORECTAL LIVER METASTASES, Cancer, 83(5), 1998, pp. 882-888
Authors:
DURANDZALESKI I
ROCHE B
BUYSE M
CARLSON R
OCONNELL MJ
ROUGIER P
CHANG AE
SONDAK VK
KEMENY MM
ALLENMERSH TG
FAGNIEZ PL
LEBOURGEOIS JP
PIEDBOIS P
Citation: I. Durandzaleski et al., ECONOMIC-IMPLICATIONS OF HEPATIC ARTERIAL INFUSION CHEMOTHERAPY IN TREATMENT OF NONRESECTABLE COLORECTAL LIVER METASTASES, Journal of the National Cancer Institute, 89(11), 1997, pp. 790-795
Citation: I. Durandzaleski et G. Depourvourville, INTERNATIONAL PRACTITIONER DATA-BANK AS A QUALITY TOOL - ARE WE USINGBEHAVIOR CONTROL IN THE RIGHT ENVIRONMENT, International journal for quality in health care, 9(5), 1997, pp. 329-332
Citation: I. Durandzaleski et al., AN ATTEMPT TO SAVE MONEY BY USING MANDATORY PRACTICE GUIDELINES IN FRANCE, BMJ. British medical journal, 315(7113), 1997, pp. 943-946
Authors:
DURANDZALESKI I
DELAUNAY L
LANGERON O
BELDA E
ASTIER A
BRUNBUISSON C
Citation: I. Durandzaleski et al., INFECTION RISK AND COST-EFFECTIVENESS OF COMMERCIAL BAGS OR GLASS BOTTLES FOR TOTAL PARENTERAL-NUTRITION, Infection control and hospital epidemiology, 18(3), 1997, pp. 183-188
Citation: I. Durandzaleski et C. Chaix, ECONOMIC-EVALUATION OF HEMATOPOIETIC GROW TH-FACTORS IN THE TREATMENTOF MALIGNANT HEMOPATHIES, La Revue de medecine interne, 18(8), 1997, pp. 662-667
Authors:
DREYFUS M
KAPLAN C
VERDY E
SCHLEGEL N
DURANDZALESKI I
TCHERNIA G
AUJARD Y
BAUMANN C
BLOT P
BOISSINOT C
HURTAUDROUX MF
OURY JF
BLUMBOISGARD C
DAFFOS F
FORESTIER F
FERNANDEZ H
PONS JC
VIAL M
UZAN S
Citation: M. Dreyfus et al., FREQUENCY OF IMMUNE THROMBOCYTOPENIA IN NEWBORNS - A PROSPECTIVE-STUDY, Blood, 89(12), 1997, pp. 4402-4406
Authors:
DURANDZALESKI I
SCHLEGEL N
BLUMBOISGARD C
UZAN S
DREYFUS M
KAPLAN C
AUJARD Y
BAUMANN C
BLOT P
BOISSINOT C
DAFFOS F
FERNANDEZ H
FORESTIER F
HURTAUDROUX F
OURY JF
PONS JC
TCHERNIA G
VERDY E
Citation: I. Durandzaleski et al., SCREENING PRIMIPAROUS WOMEN AND NEWBORNS FOR FETAL NEONATAL ALLOIMMUNE THROMBOCYTOPENIA - A PROSPECTIVE COMPARISON OF EFFECTIVENESS AND COSTS/, American journal of perinatology, 13(7), 1996, pp. 423-431
Authors:
DURANDZALESKI I
BASTUJIGARIN S
ZALESKI S
WEIL B
ROSTOKER G
Citation: I. Durandzaleski et al., A COST-ANALYSIS OF THE PREVENTION OF END-STAGE RENAL-DISEASE - IMMUNOGLOBULIN THERAPY FOR IGA NEPHROPATHY, Medical decision making, 16(4), 1996, pp. 326-334
Authors:
DURANDZALESKI I
LECLERQ R
BAGOT M
LEMAIRE F
REVUZ J
SPETEBROODT Y
ZAFRANI ES
ROCHANT H
Citation: I. Durandzaleski et al., MAKING CHOICES IN-HOSPITAL RESOURCES ALLOCATION - THE USE OF AN ASSESSMENT-TOOL TO DECIDE WHICH NEW PROJECTS ARE FINANCED, International journal of technology assessment in health care, 12(1), 1996, pp. 163-171
Authors:
DURANDZALESKI I
WAISSMAN R
LANG P
WEIL B
FOURY M
BONNET F
Citation: I. Durandzaleski et al., NONPROCUREMENT OF TRANSPLANTABLE ORGANS IN A TERTIARY CARE HOSPITAL -A FOCUS ON SOCIOLOGICAL CAUSES, Transplantation, 62(9), 1996, pp. 1224-1229
Authors:
POISSONSALOMON AS
LUCIDARME O
DURANDZALESKI I
MONTAGNE JP
Citation: As. Poissonsalomon et al., UNILATERAL INGUINAL-HERNIA IN INFANTS - C OSTS, RISKS AND BENEFITS OFHERNIOGRAPHY .1. METHODOLOGY, Journal de radiologie, 76(6), 1995, pp. 353-358
Authors:
LUCIDARME O
POISSONSALOMON AS
DURANDZALESKI I
GRUNER M
MONTAGNE JP
Citation: O. Lucidarme et al., UNILATERAL INGUINAL-HERNIA IN INFANTS - C OSTS, RISKS AND BENEFITS OFHERNIOGRAPHY .2. DECISION-ANALYSIS RESULTS, Journal de radiologie, 76(6), 1995, pp. 359-363
Authors:
ROSTOKER G
DURANDZALESKI I
PETITPHAR M
BENMAADI A
JAZAERLI N
RADIER C
RAHMOUNI A
MATHIEU D
VASILE N
ROSSO J
MEIGNAN M
REMY P
LANG P
WEIL B
Citation: G. Rostoker et al., PREVENTION OF THROMBOTIC COMPLICATIONS OF THE NEPHROTIC SYNDROME BY THE LOW-MOLECULAR-WEIGHT HEPARIN ENOXAPARIN, Nephron, 69(1), 1995, pp. 20-28
Citation: I. Durandzaleski et S. Zaleski, DEALE-ING AND DISCOUNTING - A SIMPLE WAY TO COMPUTE THE ACCRUED COSTSOF PREVENTIVE STRATEGIES, Medical decision making, 14(1), 1994, pp. 98-103
Authors:
DURANDZALESKI I
GOLDFARB B
BLUMBOISGARD C
DRUEKE T
KREIS H
Citation: I. Durandzaleski et al., COST OF TREATING PREDIALYSIS PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, Nephrology, dialysis, transplantation, 8(4), 1993, pp. 311-314